Home Multimedia Podcasts TAKING THE RISK OUT OF CLINICAL DEVELOPMENT TAKING THE RISK OUT OF CLINICAL DEVELOPMENT August 30, 2007 – GEN’s Editor-in-Chief John Sterling interviews Kenneth Carter, Ph.D., President and CEO, Avalon Pharmaceuticals /wp-content/uploads/2018/09/gc133_8_30_2007.mp3 PodcastsResourcesClinical developmentDrug development (Pharmacology)Drug research and developmentGeneticsGenomicsOMICSPharmacologyResearch and developmentResearch resources
